Evaluation and Treatment of High-Risk Patients with Early-Stage Lung Cancer

Clinics in Chest Medicine

Volumn 32, Issue 4, 2011, Pages 783-797

  Mehta, Hiren J ^a   Ross, Christopher ^b   Silvestri, Gerard A ^a   Decker, Roy H ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Elderly; Lung cancer; Preoperative assessment; Segmentectomy; Stereotactic body radiotherapy; Wedge resection

Indexed keywords

APNEA; BREATHING DISORDER; CANCER STAGING; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DERMATITIS; DYSPNEA; FATIGUE; FIBEROPTIC BRONCHOSCOPY; HIGH RISK PATIENT; HUMAN; LUNG CANCER; LUNG FUNCTION TEST; LUNG LOBECTOMY; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MEDICAL DECISION MAKING; MEDICAL HISTORY; MORBIDITY; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT SELECTION; PHASE 1 CLINICAL TRIAL (TOPIC); PHYSICAL EXAMINATION; PLEURA EFFUSION; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STEREOTACTIC BODY RADIATION THERAPY; SURGICAL MORTALITY; SURGICAL TECHNIQUE; THORAX PAIN; TREATMENT CONTRAINDICATION; TREATMENT REFUSAL; VIDEO ASSISTED THORACOSCOPIC SURGERY; WEAKNESS;

AGE FACTORS; CARCINOMA, NON-SMALL-CELL LUNG; CATHETER ABLATION; DECISION MAKING; HUMANS; INTERDISCIPLINARY COMMUNICATION; LUNG NEOPLASMS; NEOPLASM STAGING; PATIENT PREFERENCE; PNEUMONECTOMY; PREOPERATIVE CARE; RADIOSURGERY; RESPIRATORY FUNCTION TESTS; RISK;

EID: 80455176708     PISSN: 02725231     EISSN: 15578216     Source Type: Journal    
DOI: 10.1016/j.ccm.2011.08.011     Document Type: Review

References (146)

1. Myrdal G., Gustafsson G., Lambe M., et al. Outcome after lung cancer surgery. Factors predicting early mortality and major morbidity. Eur J Cardiothorac Surg 2001, 20(4):694-699.
2. Mountain C.F. Revisions in the international system for staging lung cancer. Chest 1997, 111(6):1710-1717.
3. Boffa D.J., Allen M.S., Grab J.D., et al. Data from The Society of Thoracic Surgeons General Thoracic Surgery database: the surgical management of primary lung tumors. J Thorac Cardiovasc Surg 2008, 135(2):247-254.
4. Scott W.J., Howington J., Feigenberg S., et al. Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007, 132(Suppl 3):234S-242S.
5. Williams D.E., Pairolero P.C., Davis C.S., et al. Survival of patients surgically treated for stage I lung cancer. J Thorac Cardiovasc Surg 1981, 82(1):70-76.
6. Cheung M.C., Hamilton K., Sherman R., et al. Impact of teaching facility status and high-volume centers on outcomes for lung cancer resection: an examination of 13,469 surgical patients. Ann Surg Oncol 2009, 16(1):3-13.
7. Meguid R.A., Brooke B.S., Chang D.C., et al. Are surgical outcomes for lung cancer resections improved at teaching hospitals?. Ann Thorac Surg 2008, 85(3):1015-1024. [discussion: 1024-5].
8. Berry M.F., Villamizar-Ortiz N.R., Tong B.C., et al. Pulmonary function tests do not predict pulmonary complications after thoracoscopic lobectomy. Ann Thorac Surg 2010, 89(4):1044-1051. [discussion: 1051-2].
9. Goodney P.P., Lucas F.L., Stukel T.A., et al. Surgeon specialty and operative mortality with lung resection. Ann Surg 2005, 241(1):179-184.
10. Mason D.P., Subramanian S., Nowicki E.R., et al. Impact of smoking cessation before resection of lung cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database study. Ann Thorac Surg 2009, 88(2):362-370. [discussion: 370-1].
11. Silvestri G.A., Handy J., Lackland D., et al. Specialists achieve better outcomes than generalists for lung cancer surgery. Chest 1998, 114(3):675-680.
12. Graham E.A., Berck M. Principles versus details in the treatment of acute empyema. Ann Surg 1933, 98(4):520-527.
13. Bolliger C.T., Koegelenberg C.F., Kendal R. Preoperative assessment for lung cancer surgery. Curr Opin Pulm Med 2005, 11(4):301-306.
14. Datta D., Lahiri B. Preoperative evaluation of patients undergoing lung resection surgery. Chest 2003, 123(6):2096-2103.
15. Ferguson M.K., Little L., Rizzo L., et al. Diffusing capacity predicts morbidity and mortality after pulmonary resection. J Thorac Cardiovasc Surg 1988, 96(6):894-900.
16. Ferguson M.K., Vigneswaran W.T. Diffusing capacity predicts morbidity after lung resection in patients without obstructive lung disease. Ann Thorac Surg 2008, 85(4):1158-1164. [discussion: 1164-5].
17. Liptay M.J., Basu S., Hoaglin M.C., et al. Diffusion lung capacity for carbon monoxide (DLCO) is an independent prognostic factor for long-term survival after curative lung resection for cancer. J Surg Oncol 2009, 100(8):703-707.
18. Handy J.R., Asaph J.W., Skokan L., et al. What happens to patients undergoing lung cancer surgery? Outcomes and quality of life before and after surgery. Chest 2002, 122(1):21-30.
19. Colice G.L., Shafazand S., Griffin J.P., et al. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 2007, 132(Suppl 3):161S-177S.
20. Bolliger C.T., Guckel C., Engel H., et al. Prediction of functional reserves after lung resection: comparison between quantitative computed tomography, scintigraphy, and anatomy. Respiration 2002, 69(6):482-489.
21. Smulders S.A., Smeenk F.W., Janssen-Heijnen M.L., et al. Actual and predicted postoperative changes in lung function after pneumonectomy: a retrospective analysis. Chest 2004, 125(5):1735-1741.
22. Giordano A., Calcagni M.L., Meduri G., et al. Perfusion lung scintigraphy for the prediction of postlobectomy residual pulmonary function. Chest 1997, 111(6):1542-1547.
23. Zeiher B.G., Gross T.J., Kern J.A., et al. Predicting postoperative pulmonary function in patients undergoing lung resection. Chest 1995, 108(1):68-72.
24. Ali M.K., Mountain C.F., Ewer M.S., et al. Predicting loss of pulmonary function after pulmonary resection for bronchogenic carcinoma. Chest 1980, 77(3):337-342.
25. Bria W.F., Kanarek D.J., Kazemi H. Prediction of postoperative pulmonary function following thoracic operations. Value of ventilation-perfusion scanning. J Thorac Cardiovasc Surg 1983, 86(2):186-192.
26. Corris P.A., Ellis D.A., Hawkins T., et al. Use of radionuclide scanning in the preoperative estimation of pulmonary function after pneumonectomy. Thorax 1987, 42(4):285-291.
27. Holden D.A., Rice T.W., Stelmach K., et al. Exercise testing, 6-min walk, and stair climb in the evaluation of patients at high risk for pulmonary resection. Chest 1992, 102(6):1774-1779.
28. Ninan M., Sommers K.E., Landreneau R.J., et al. Standardized exercise oximetry predicts postpneumonectomy outcome. Ann Thorac Surg 1997, 64(2):328-332. [discussion: 332-3].
29. Olsen G.N., Bolton J.W., Weiman D.S., et al. Stair climbing as an exercise test to predict the postoperative complications of lung resection. Two years' experience. Chest 1991, 99(3):587-590.
30. Morice R.C., Peters E.J., Ryan M.B., et al. Exercise testing in the evaluation of patients at high risk for complications from lung resection. Chest 1992, 101(2):356-361.
31. Pate P., Tenholder M.F., Griffin J.P., et al. Preoperative assessment of the high-risk patient for lung resection. Ann Thorac Surg 1996, 61(5):1494-1500.
32. Brunelli A., Belardinelli R., Refai M., et al. Peak oxygen consumption during cardiopulmonary exercise test improves risk stratification in candidates to major lung resection. Chest 2009, 135(5):1260-1267.
33. Raz D.J., Zell J.A., Ou S.H., et al. Natural history of stage I non-small cell lung cancer: implications for early detection. Chest 2007, 132(1):193-199.
34. Ginsberg R.J., Rubinstein L.V. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995, 60(3):615-622.
35. Ferguson M.K., Lehman A.G. Sleeve lobectomy or pneumonectomy: optimal management strategy using decision analysis techniques. Ann Thorac Surg 2003, 76(6):1782-1788.
36. Jensik R.J., Faber L.P., Milloy F.J., et al. Segmental resection for lung cancer. A fifteen-year experience. J Thorac Cardiovasc Surg 1973, 66(4):563-572.
37. Ginsberg R.J., Hill L.D., Eagan R.T., et al. Modern thirty-day operative mortality for surgical resections in lung cancer. J Thorac Cardiovasc Surg 1983, 86(5):654-658.
38. Wada H., Nakamura T., Nakamoto K., et al. Thirty-day operative mortality for thoracotomy in lung cancer. J Thorac Cardiovasc Surg 1998, 115(1):70-73.
39. Keenan R.J., Landreneau R.J., Maley R.H., et al. Segmental resection spares pulmonary function in patients with stage I lung cancer. Ann Thorac Surg 2004, 78(1):228-233. [discussion: 228-33].
40. Harada H., Okada M., Sakamoto T., et al. Functional advantage after radical segmentectomy versus lobectomy for lung cancer. Ann Thorac Surg 2005, 80(6):2041-2045.
41. Mery C.M., Pappas A.N., Bueno R., et al. Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. Chest 2005, 128(1):237-245.
42. Kilic A., Schuchert M.J., Pettiford B.L., et al. Anatomic segmentectomy for stage I non-small cell lung cancer in the elderly. Ann Thorac Surg 2009, 87(6):1662-1666. [discussion: 1667-8].
43. Okada M., Nishio W., Sakamoto T., et al. Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection. J Thorac Cardiovasc Surg 2005, 129(1):87-93.
44. El-Sherif A., Fernando H.C., Santos R., et al. Margin and local recurrence after sublobar resection of non-small cell lung cancer. Ann Surg Oncol 2007, 14(8):2400-2405.
45. Ketchedjian A., Daly B., Landreneau R., et al. Sublobar resection for the subcentimeter pulmonary nodule. Semin Thorac Cardiovasc Surg 2005, 17(2):128-133.
46. Martin-Ucar A.E., Nakas A., Pilling J.E., et al. A case-matched study of anatomical segmentectomy versus lobectomy for stage I lung cancer in high-risk patients. Eur J Cardiothorac Surg 2005, 27(4):675-679.
47. Owens J.M., Roberts D.B., Myers J.N. The role of postoperative adjuvant radiation therapy in the treatment of mucosal melanomas of the head and neck region. Arch Otolaryngol Head Neck Surg 2003, 129(8):864-868.
48. Edwards J.G., Duthie D.J., Waller D.A. Lobar volume reduction surgery: a method of increasing the lung cancer resection rate in patients with emphysema. Thorax 2001, 56(10):791-795.
49. Fishman A., Martinez F., Naunheim K., et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003, 348(21):2059-2073.
50. Cooper J.D., Patterson G.A., Sundaresan R.S., et al. Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. J Thorac Cardiovasc Surg 1996, 112(5):1319-1329. [discussion: 1329-30].
51. Choong C.K., Meyers B.F., Battafarano R.J., et al. Lung cancer resection combined with lung volume reduction in patients with severe emphysema. J Thorac Cardiovasc Surg 2004, 127(5):1323-1331.
52. Flores R.M., Alam N. Video-assisted thoracic surgery lobectomy (VATS), open thoracotomy, and the robot for lung cancer. Ann Thorac Surg 2008, 85(2):S710-S715.
53. Farjah F., Wood D.E., Mulligan M.S., et al. Safety and efficacy of video-assisted versus conventional lung resection for lung cancer. J Thorac Cardiovasc Surg 2009, 137(6):1415-1421.
54. Onaitis M.W., Petersen R.P., Balderson S.S., et al. Thoracoscopic lobectomy is a safe and versatile procedure: experience with 500 consecutive patients. Ann Surg 2006, 244(3):420-425.
55. McKenna R.J., Houck W., Fuller C.B. Video-assisted thoracic surgery lobectomy: experience with 1,100 cases. Ann Thorac Surg 2006, 81(2):421-425. [discussion: 425-6].
56. Hiraki T., Gobara H., Mimura H., et al. Percutaneous radiofrequency ablation of lung cancer. Lancet Oncol 2008, 9(7):604-605.
57. Gazelle G.S., Goldberg S.N., Solbiati L., et al. Tumor ablation with radio-frequency energy. Radiology 2000, 217(3):633-646.
58. Nahum Goldberg S., Dupuy D.E. Image-guided radiofrequency tumor ablation: challenges and opportunities-part I. J Vasc Interv Radiol 2001, 12(9):1021-1032.
59. Dupuy D.E., Zagoria R.J., Akerley W., et al. Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol 2000, 174(1):57-59.
60. Chan V.O., McDermott S., Malone D.E., et al. Percutaneous radiofrequency ablation of lung tumors: evaluation of the literature using evidence-based techniques. J Thorac Imaging 2011, 26(1):18-26.
61. Lencioni R., Crocetti L., Cioni R., et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 2008, 9(7):621-628.
62. Simon C.J., Dupuy D.E., DiPetrillo T.A., et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 2007, 243(1):268-275.
63. Fernando H.C., De Hoyos A., Landreneau R.J., et al. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. J Thorac Cardiovasc Surg 2005, 129(3):639-644.
64. Jin G.Y., Lee J.M., Lee Y.C., et al. Primary and secondary lung malignancies treated with percutaneous radiofrequency ablation: evaluation with follow-up helical CT. AJR Am J Roentgenol 2004, 183(4):1013-1020.
65. Lee J.M., Jin G.Y., Goldberg S.N., et al. Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology 2004, 230(1):125-134.
66. Hiraki T., Sakurai J., Tsuda T., et al. Risk factors for local progression after percutaneous radiofrequency ablation of lung tumors: evaluation based on a preliminary review of 342 tumors. Cancer 2006, 107(12):2873-2880.
67. de Baère T., Palussière J., Aupérin A., et al. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology 2006, 240(2):587-596.
68. Pennathur A., Luketich J.D., Abbas G., et al. Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients. J Thorac Cardiovasc Surg 2007, 134(4):857-864.
69. Hiraki T., Gobara H., Iishi T., et al. Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: results in 20 nonsurgical candidates. J Thorac Cardiovasc Surg 2007, 134(5):1306-1312.
70. Choe Y.H., Kim S.R., Lee K.S., et al. The use of PTC and RFA as treatment alternatives with low procedural morbidity in non-small cell lung cancer. Eur J Cancer 2009, 45(10):1773-1779.
71. Lanuti M., Sharma A., Digumarthy S.R., et al. Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2009, 137(1):160-166.
72. Haasbeek C.J., Slotman B.J., Senan S. Radiotherapy for lung cancer: clinical impact of recent technical advances. Lung Cancer 2009, 64(1):1-8.
73. Ross C.S., Hussey D.H., Pennington E.C., et al. Analysis of movement of intrathoracic neoplasms using ultrafast computerized tomography. Int J Radiat Oncol Biol Phys 1990, 18(3):671-677.
74. Keall P. 4-Dimensional computed tomography imaging and treatment planning. Semin Radiat Oncol 2004, 14(1):81-90.
75. Grills I.S., Hugo G., Kestin L.L., et al. Image-guided radiotherapy via daily online cone-beam CT substantially reduces margin requirements for stereotactic lung radiotherapy. Int J Radiat Oncol Biol Phys 2008, 70(4):1045-1056.
76. Fakiris A.J., McGarry R.C., Yiannoutsos C.T., et al. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 2009, 75(3):677-682.
77. Timmerman R., Paulus R., Galvin J., et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010, 303(11):1070-1076.
78. Zimmermann F.B., Geinitz H., Schill S., et al. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. Lung Cancer 2005, 48(1):107-114.
79. Nyman J., Johansson K.A., Hultén U. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer-mature results for medically inoperable patients. Lung Cancer 2006, 51(1):97-103.
80. Fritz P., Kraus H.J., Mühlnickel W., et al. Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases. Radiat Oncol 2006, 1:30.
81. Baumann P., Nyman J., Lax I., et al. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Acta Oncol 2006, 45(7):787-795.
82. Nagata Y., Takayama K., Matsuo Y., et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005, 63(5):1427-1431.
83. Xia T., Li H., Sun Q., et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2006, 66(1):117-125.
84. Ricardi U., Filippi A.R., Guarneri A., et al. Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial. Lung Cancer 2010, 68(1):72-77.
85. Baumann P., Nyman J., Hoyer M., et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 2009, 27(20):3290-3296.
86. Timmerman R., McGarry R., Yiannoutsos C., et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006, 24(30):4833-4839.
87. Onishi H., Shirato H., Nagata Y., et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2007, 2(7 Suppl 3):S94-S100.
88. Timmerman R., Papiez L., McGarry R., et al. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 2003, 124(5):1946-1955.
89. McGarry R.C., Papiez L., Williams M., et al. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys 2005, 63(4):1010-1015.
90. Krol A.D., Aussems P., Noordijk E.M., et al. Local irradiation alone for peripheral stage I lung cancer: could we omit the elective regional nodal irradiation?. Int J Radiat Oncol Biol Phys 1996, 34(2):297-302.
91. Sandler H.M., Curran W.J., Turrisi A.T. The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1990, 19(1):9-13.
92. Kaskowitz L., Graham M.V., Emami B., et al. Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1993, 27(3):517-523.
93. Onishi H., Shirato H., Nagata Y., et al. Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery?. Int J Radiat Oncol Biol Phys 2010, [Epub ahead of print].
94. Mountain C.F. The international system for staging lung cancer. Semin Surg Oncol 2000, 18(2):106-115.
95. Asamura H., Goya T., Koshiishi Y., et al. A Japanese lung cancer registry study: prognosis of 13,010 resected lung cancers. J Thorac Oncol 2008, 3(1):46-52.
96. Naruke T., Tsuchiya R., Kondo H., et al. Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience. Ann Thorac Surg 2001, 71(6):1759-1764.
97. Grills I.S., Mangona V.S., Welsh R., et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol 2010, 28(6):928-935.
98. Nagata Y., Hiraoka M., Shibata T., et al. A phase II trial of stereotactic body radiation therapy for operable T1N0M0 non-small cell lung cancer: Japan Clinical Oncology Group (JCOG0403). Int J Radiat Oncol Biol Phys 2010, 78:S27-S28.
99. NIH Clinical Trials database. Available at: Accessed March 13, 2011. http://www.clinicaltrials.gov.
100. Carey Sampson M., Katz A., Constine L.S. Stereotactic body radiation therapy for extracranial oligometastases: does the sword have a double edge?. Semin Radiat Oncol 2006, 16(2):67-76.
101. Trovo M., Linda A., El Naqa I., et al. Early and late lung radiographic injury following stereotactic body radiation therapy (SBRT). Lung Cancer 2010, 69(1):77-85.
102. Stephans K.L., Djemil T., Reddy C.A., et al. Comprehensive analysis of pulmonary function test (PFT) changes after stereotactic body radiotherapy (SBRT) for stage I lung cancer in medically inoperable patients. J Thorac Oncol 2009, 4(7):838-844.
103. Lagerwaard F.J., Haasbeek C.J., Smit E.F., et al. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008, 70(3):685-692.
104. Senan S., Haasbeek N.J., Smit E.F., et al. Stereotactic radiotherapy for centrally located early-stage lung tumors. J Clin Oncol 2007, 25(4):464. [author reply: 465].
105. Guckenberger M., Heilman K., Wulf J., et al. Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): results of a serial follow-up CT study. Radiother Oncol 2007, 85(3):435-442.
106. Hoopes D.J., Tann M., Fletcher J.W., et al. FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer. Lung Cancer 2007, 56(2):229-234.
107. Takeda A., Kunieda E., Takeda T., et al. Possible misinterpretation of demarcated solid patterns of radiation fibrosis on CT scans as tumor recurrence in patients receiving hypofractionated stereotactic radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 2008, 70(4):1057-1065.
108. Fleming I.D. Multidisciplinary treatment planning. Tumor boards. Cancer 1989, 64(Suppl 1):279-281. [discussion: 282-4].
109. Chang J.H., Vines E., Bertsch H., et al. The impact of a multidisciplinary breast cancer center on recommendations for patient management: the University of Pennsylvania experience. Cancer 2001, 91(7):1231-1237.
110. Burton S., Brown G., Daniels I.R., et al. MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins?. Br J Cancer 2006, 94(3):351-357.
111. Newman E.A., Guest A.B., Helvie M.A., et al. Changes in surgical management resulting from case review at a breast cancer multidisciplinary tumor board. Cancer 2006, 107(10):2346-2351.
112. Abraham N.S., Gossey J.T., Davila J.A., et al. Receipt of recommended therapy by patients with advanced colorectal cancer. Am J Gastroenterol 2006, 101(6):1320-1328.
113. Lutterbach J., Pagenstecher A., Spreer J., et al. The brain tumor board: lessons to be learned from an interdisciplinary conference. Onkologie 2005, 28(1):22-26.
114. Zorbas H., Barraclough B., Rainbird K., et al. Multidisciplinary care for women with early breast cancer in the Australian context: what does it mean?. Med J Aust 2003, 179(10):528-531.
115. Junor E.J., Hole D.J., Gillis C.R. Management of ovarian cancer: referral to a multidisciplinary team matters. Br J Cancer 1994, 70(2):363-370.
116. Sainsbury R., Haward B., Rider L., et al. Influence of clinician workload and patterns of treatment on survival from breast cancer. Lancet 1995, 345(8960):1265-1270.
117. Gabel M., Hilton N.E., Nathanson S.D. Multidisciplinary breast cancer clinics. Do they work?. Cancer 1997, 79(12):2380-2384.
118. Petty J.K., Vetto J.T. Beyond doughnuts: tumor board recommendations influence patient care. J Cancer Educ 2002, 17(2):97-100.
119. Gatcliffe T.A., Coleman R.L. Tumor board: more than treatment planning-a 1-year prospective survey. J Cancer Educ 2008, 23(4):235-237.
120. Silvestri G., Pritchard R., Welch H.G. Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews. BMJ 1998, 317(7161):771-775.
121. Brundage M.D., Feldman-Stewart D., Cosby R., et al. Cancer patients' attitudes toward treatment options for advanced non-small cell lung cancer: implications for patient education and decision support. Patient Educ Couns 2001, 45(2):149-157.
122. Weeks J.C., Cook E.F., O'Day S.J., et al. Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA 1998, 279(21):1709-1714.
123. Potosky A.L., Saxman S., Wallace R.B., et al. Population variations in the initial treatment of non-small-cell lung cancer. J Clin Oncol 2004, 22(16):3261-3268.
124. McCann J., Artinian V., Duhaime L., et al. Evaluation of the causes for racial disparity in surgical treatment of early stage lung cancer. Chest 2005, 128(5):3440-3446.
125. Farjah F., Wood D.E., Yanez N.D., et al. Racial disparities among patients with lung cancer who were recommended operative therapy. Arch Surg 2009, 144(1):14-18.
126. Margolis M.L., Christie J.D., Silvestri G.A., et al. Racial differences pertaining to a belief about lung cancer surgery: results of a multicenter survey. Ann Intern Med 2003, 139(7):558-563.
127. Cykert S., Dilworth-Anderson P., Monroe M.H., et al. Factors associated with decisions to undergo surgery among patients with newly diagnosed early-stage lung cancer. JAMA 2010, 303(23):2368-2376.
128. Clever S.L., Edwards K.A., Feudtner C., et al. Ethics and communication: does students' comfort addressing: ethical issues vary by specialty team?. J Gen Intern Med 2001, 16(8):559-563.
129. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2009. CA Cancer J Clin 2009, 59(4):225-249.
130. Havlik R.J., Yancik R., Long S., et al. The National Institute on Aging and the National Cancer Institute SEER collaborative study on comorbidity and early diagnosis of cancer in the elderly. Cancer 1994, 74(Suppl 7):2101-2106.
131. Owonikoko T.K., Ragin C.C., Belani C.P., et al. Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database. J Clin Oncol 2007, 25(35):5570-5577.
132. Balducci L. Geriatric oncology: challenges for the new century. Eur J Cancer 2000, 36(14):1741-1754.
133. Extermann M. Measuring comorbidity in older cancer patients. Eur J Cancer 2000, 36(4):453-471.
134. Hutchins L.F., Unger J.M., Crowley J.J., et al. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999, 341(27):2061-2067.
135. Brown J.S., Eraut D., Trask C., et al. Age and the treatment of lung cancer. Thorax 1996, 51(6):564-568.
136. Janssen-Heijnen M.L., Schipper R.M., Razenberg P.P., et al. Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study. Lung Cancer 1998, 21(2):105-113.
137. Hehn B., Haponik E.F. Flexible bronchoscopy in the elderly. Clin Chest Med 2001, 22(2):301-309. viii.
138. Brown T.S., Kanthapillai P. Transthoracic needle biopsy for suspected thoracic malignancy in elderly patients using CT guidance. Clin Radiol 1998, 53(2):116-119.
139. Peake M.D., Thompson S., Lowe D., et al. Ageism in the management of lung cancer. Age Ageing 2003, 32(2):171-177.
140. Anderson R.N. United States life tables, 1997. Natl Vital Stat Rep 1999, 47(28):1-37.
141. Sherman S., Guidot C.E. The feasibility of thoracotomy for lung cancer in the elderly. JAMA 1987, 258(7):927-930.
142. Ishida T., Yokoyama H., Kaneko S., et al. Long-term results of operation for non-small cell lung cancer in the elderly. Ann Thorac Surg 1990, 50(6):919-922.
143. Morandi U., Stefani A., Golinelli M., et al. Results of surgical resection in patients over the age of 70 years with non small-cell lung cancer. Eur J Cardiothorac Surg 1997, 11(3):432-439.
144. Kamiyoshihara M., Kawashima O., Ishikawa S., et al. Long-term results after pulmonary resection in elderly patients with non-small cell lung cancer. J Cardiovasc Surg (Torino) 2000, 41(3):483-486.
145. Palma D.A., Tyldesley S., Sheehan F., et al. Stage I non-small cell lung cancer (NSCLC) in patients aged 75 years and older: does age determine survival after radical treatment?. J Thorac Oncol 2010, 5(6):818-824.
146. Gauden S.J., Tripcony L. The curative treatment by radiation therapy alone of Stage I non-small cell lung cancer in a geriatric population. Lung Cancer 2001, 32(1):71-79.